Article
IPO & Listings FTSE 100 Applied Nutrition

Applied Nutrition founders sell £19.25m of shares

Thomas Ryder and Steven Granite sold 7 million shares at 275p each in the first disposal since the sports nutrition company's IPO nearly two years ago.

by tickstock newsroom
The image showcases a white scoop lying on a pile of fine powder. The powder appears to be a light-colored substance, possibly a protein or baking ingredient, set against a neutral background. — Credit: Photo by Alex Saks on Unsplash c Photo by Alex Saks on Unsplash

Applied Nutrition (LSE:APN), the sports nutrition and wellness brand, confirmed that founders Thomas Ryder and Steven Granite sold 7m shares at 275p each, raising approximately £19.25m.

The shares represent roughly 2.80% of the company's issued share capital.

It marks the first sale of shares by either founder since Applied Nutrition listed in October 2024, and the company said the move diversifies their asset base.

Ryder remains the company's largest shareholder after the sale, holding 81.16m shares, equivalent to 32.46% of issued share capital.

Both sellers have agreed not to dispose of further shares for 180 days, subject to exceptions and a waiver from Panmure Liberum, which acted as sole bookrunner.

Applied Nutrition is not party to the placing and will receive none of the proceeds.

The trade completed on 11 September, with settlement expected on 15 September.

News Intelligence what this means for the company

Founders Thomas Ryder and Steven Granite sold 7m shares (2.80% of the company) at 275p for £19.25m on 11 September—the first insider disposal since the October 2024 IPO. The sale is modest relative to Ryder's remaining 32.46% stake and the company's £15.9m net cash position; it signals founder diversification rather than distress, and both have committed to a 180-day lock-up.

Investment case

The sale does not materially alter Applied Nutrition's capital structure or growth trajectory. Ryder remains the dominant shareholder, the company retains full cash resources for the Nutrablend integration and FY27 guidance, and the lock-up agreement limits near-term further dilution.

Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.

Content is for informational purposes only, not financial advice.

by tickstock newsroom